Petros Pharmaceuticals, Inc.
- PTPI
- OTC
- Drug Manufacturers - Specialty & Generic
- Erectile Dysfunction Treatment (Stendra)
- Men's Health Pharmaceuticals
- PDE-5 Inhibitors
$0.00
Today −10.00%Quote Oct 16, 2026, 08:00 PM UTC
−34.15%over the last month
Max drawdown −60.3%From 1-month high −60.3%3 months −41.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$114,405
Quote Oct 16
Next earnings
Dec 2
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$0.00
7.4% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PTPIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug Manufacturers - Specialty & Generic
Employees
3